Pharma Two B logo — Clinical stage pharma company striving to improve patients q...

Pharma Two B

Clinical stage pharma company striving to improve patients quality of life by developing innovative combination products

Founded 2007 Israel Israel 7 employees Series C Total: $38.00M Biopharma, Biotechnology +1

General Information

Company Name Pharma Two B
Founded Year 2007
Location Israel Israel +1
Employees 7
Industries Biopharma, Biotechnology, Pharmaceutical
Funding Stage Series C
Social

Get notified when Pharma Two B moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Pharma Two B

Pharma Two B is a clinical-stage pharma company with a focus on developing innovative combination products to enhance the quality of life for patients. The company leverages its expertise to identify and characterize potential synergistic drug combinations, aiming to deliver heightened therapeutic effects with improved safety profiles. Pharma Two B's primary goal is to address unmet medical needs by creating clinically meaningful and safe combination products. Their lead investigational product, P2B001, has completed successful Phase IIb and Phase III studies for the treatment of early Parkinson’s Disease (PD). Founded in 2007 and headquartered in Israel, the company secured a significant $30.00M Series C investment in February 27, 2017 from investors including JK&B Capital, Israel Biotech Fund, JVC, and Generali Financial Holding. Pharma Two B's efforts in developing novel pharmaceutical solutions, particularly in the biopharma, biotechnology, and pharmaceutical industries, showcase its potential for significant impact in the healthcare sector.

Taxonomy: Pharma, Drug Development, Clinical Trials, Parkinson's Disease, Cancer, Combination Products, Therapeutic Innovation, Clinical Stage, Regulatory Pathways, Patient Advocacy, Fixed-Dose Combinations, Synergistic Effects, Unmet Medical Needs, Value-added Products

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Series C •••••• 4
Investor Investor
•••• ••••
27 Feb 2017
Series B •••••• 2
Investor
•••• ••••
23 Oct 2012

Pharma Two B Alternatives & Competitors

Pharma Two B vs

Embarking on a journey to better health through innovative biotechnology solutions for brain, geneti...

Post Ipo Equity
Biopharma, Biotechnology
Pharma Two B vs
CG Oncology
CG Oncology United States

Attacking Bladder Cancer for a Better Tomorrow

Series F
121 employees
Biotechnology, Health Care
Pharma Two B vs

Driving Oncology Innovation with Advanced Chemotherapeutic Solutions

Post Ipo Equity
Biopharma, Biotechnology

FAQ About Pharma Two B

Clinical stage pharma company striving to improve patients quality of life by developing innovative combination products
Pharma Two B was founded in 2007.
Pharma Two B is headquartered in Israel.
Pharma Two B operates in the following industries: Biopharma, Biotechnology, Pharmaceutical.
Pharma Two B has approximately 7 employees.
Pharma Two B has completed 2 funding rounds, raising a total of $38.00M. The latest funding stage is Series C.
Top alternatives and competitors to Pharma Two B include Raptor Pharmaceuticals, CG Oncology, CytRx, Suttons Creek, Nucleus Network. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Pharma Two B and Raptor Pharmaceuticals are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Pharma Two B and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes